Search results for "Drug Interactions"
Helping patients manage generic drug price increases
Generic drugs have recently become more expensive, from colchicine for gout to EpiPens for allergic reactions. Physicians are having trouble managing patients when their medicines suddenly rise in price.
https://immattersacp.org/archives/2019/09/helping-patients-manage-generic-drug-price-increases.htm
1 Sep 2019
MKSAP Quiz: 3-year history of dyspnea, cough
A 69-year-old man is evaluated for a three-year history of dyspnea and chronic productive cough. He was diagnosed with chronic obstructive pulmonary disease (COPD) two years ago and has been treated for three exacerbations in the past year. He is taking tiotropium, fluticasone/salmeterol, and albuterol inhalers. Which long-term treatment is most likely to reduce exacerbations?
https://immattersacp.org/weekly/archives/2019/03/05/3.htm
5 Mar 2019
Expert panel recommends SGLT2 inhibitor or GLP-1 receptor agonist for patients with type 2 diabetes and CVD
The American College of Cardiology's new decision pathway also calls for repeated HbA1c screening and detailed clinician-patient risk discussions for patients with cardiovascular disease (CVD) who are diagnosed with type 2 diabetes.
https://immattersacp.org/weekly/archives/2018/12/04/2.htm
4 Dec 2018
CDC expands recommendations for latent tuberculosis treatment
Expanded recommendations specifically include use in children, in persons co-infected with HIV/AIDS and latent tuberculosis, and by self-administration.
https://immattersacp.org/weekly/archives/2018/07/10/4.htm
10 Jul 2018
Drug interaction risks appear common among older patients being treated for epilepsy
Factors predicting higher drug interaction risk included having one or more comorbid condition versus zero comorbidities, having four or more comorbid conditions versus zero comorbidities, being eligible for the Medicare Part D Low-Income Subsidy, and not living in the northeastern U.S.
https://immattersacp.org/weekly/archives/2018/02/13/4.htm
13 Feb 2018
Gout drug concerns; monthly buprenorphine injection OK'd
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2018/02/gout-drug-concerns-monthly-buprenorphine-injection-okd.htm
1 Feb 2018
MKSAP Quiz: 1-week history of recurrent episodes of facial pain
A 36-year-old woman with relapsing-remitting MS is evaluated for a 1-week history of recurrent episodes of facial pain that are 1 to 3 seconds in duration and occur spontaneously dozens of times throughout the day. The pain is sharp, severe, and located in the right infraorbital area. During this same period, she has developed worsening bilateral lower extremity weakness and urinary incontinence. After a physical exam and lab studies, what is the most likely cause of the facial pain?
https://immattersacp.org/weekly/archives/2017/04/25/3.htm
25 Apr 2017
Guidance issued on drug-drug interactions for statins, heart meds
A new statement from the American Heart Association recommends that in patients taking amlodipine combined with simvastatin or lovastatin, the dosage of either statin should not exceed 20 mg/d, and for patients in whom statin-fibrate therapy is indicated, fenofibrate or fenofibric acid is preferred because of a lower rate of drug-drug interactions.
https://immattersacp.org/weekly/archives/2016/10/25/2.htm
25 Oct 2016
MKSAP Quiz: severe, persistent, burning pain in an assisted-living patient
An 86-year-old woman is evaluated in her assisted-living facility for pain. Four weeks ago, she developed herpetic lesions on her right posterior thorax in a T7 distribution. She was treated with acyclovir, and the lesions healed; however, she has persistent severe burning pain. The pain is so severe that she is unable to leave her bed to attend meals. Following a physical exam, which medication is the most appropriate pharmacologic therapy for this patient's pain?
https://immattersacp.org/weekly/archives/2016/05/17/3.htm
17 May 2016
Managing depression is worth the effort
Depression's impact on health is often profound and far-reaching, potentially equaling that of coronary artery disease. To provide clinicians with guidance on treatment of depression, ACP has released a new clinical practice guideline that underscores the severe burden of depression and outlines viable treatment options for patients.
https://immattersacp.org/archives/2016/05/depression.htm
1 May 2016